ES2058138T3 - Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole. - Google Patents

Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole.

Info

Publication number
ES2058138T3
ES2058138T3 ES87830386T ES87830386T ES2058138T3 ES 2058138 T3 ES2058138 T3 ES 2058138T3 ES 87830386 T ES87830386 T ES 87830386T ES 87830386 T ES87830386 T ES 87830386T ES 2058138 T3 ES2058138 T3 ES 2058138T3
Authority
ES
Spain
Prior art keywords
appropriate
pharmaceutical formulation
gastrointestinal tract
inn
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87830386T
Other languages
English (en)
Inventor
Alessandro Casini
Sandro Parti
Paolo Bucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
A Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Menarini Industrie Farmaceutiche Riunite SRL filed Critical A Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of ES2058138T3 publication Critical patent/ES2058138T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)
  • Steroid Compounds (AREA)

Abstract

USO DE BROMURO DE OTILONIO PARA APLICACION LOCAL EN EL TRACTO GASTROINTESTINAL DEL SISTEMA DIGESTIVO Y FORMULACION FARMACEUTICA PERTINENTE ADECUADA PARA TAL USO, PARA CONSEGUIR DETENER LA MOTILIDAD A FIN DE PERMITIR MANIOBRAS ENDOSCOPICAS PARA PROPOSITOS DE DIAGNOSTICO Y TERAPEUTICOS.
ES87830386T 1986-11-04 1987-11-03 Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole. Expired - Lifetime ES2058138T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8609514A IT1216283B (it) 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.

Publications (1)

Publication Number Publication Date
ES2058138T3 true ES2058138T3 (es) 1994-11-01

Family

ID=11131395

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87830386T Expired - Lifetime ES2058138T3 (es) 1986-11-04 1987-11-03 Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole.

Country Status (8)

Country Link
US (1) US4978772A (es)
EP (1) EP0270503B1 (es)
JP (1) JP2514670B2 (es)
AT (1) ATE94388T1 (es)
CA (1) CA1311419C (es)
DE (1) DE3787448T2 (es)
ES (1) ES2058138T3 (es)
IT (1) IT1216283B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503889B1 (ko) * 2002-07-20 2005-07-26 한국과학기술연구원 옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
WO2010092436A1 (en) * 2009-02-12 2010-08-19 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of simethicone and otilonium
EP2481403A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Pharmaceutical combination of otilonium and trimebutine
EP2481395A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, effervescent tablet and dry syrup of otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics

Also Published As

Publication number Publication date
US4978772A (en) 1990-12-18
IT1216283B (it) 1990-02-22
DE3787448T2 (de) 1994-01-13
CA1311419C (en) 1992-12-15
IT8609514A0 (it) 1986-11-04
DE3787448D1 (de) 1993-10-21
JPS63130530A (ja) 1988-06-02
ATE94388T1 (de) 1993-10-15
EP0270503B1 (en) 1993-09-15
EP0270503A2 (en) 1988-06-08
EP0270503A3 (en) 1990-04-18
JP2514670B2 (ja) 1996-07-10

Similar Documents

Publication Publication Date Title
Hawkey et al. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?
MX9204132A (es) Composiciones farmaceuticas que contienen rifaximin y procedimiento para su preparacion.
IT1260505B (it) Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
IT1227154B (it) Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
CL2008002943A1 (es) Compuestos derivados de acido hidroxamico; composicion farmaceutica que comprende a dicho compuesto; y su uso en la preparacion de medicamentos para el tratamiento de la proliferacion de celulas neoplasticas. (divisional de la solicitud1247-04)
ES550679A0 (es) Aparato para la localizacion de hemorragias en el tracto gastrointestinal.
ES2170223T3 (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
SE8700499D0 (sv) Novel pharmacologically active compounds
IT8821324A0 (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
IT1262993B (it) Complesso di bismuto citrato di ranitidina ed antibiotico, composizione che lo contiene e relativo metodo di produzione ed impiego
IE34676B1 (en) Benzimidazo (2,1-b) quinazolin derivatives as immuno suppressants
ES2058138T3 (es) Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole.
IT8248964A0 (it) Formulazione granulare mista ad azione prolungata, in particolareper la somministrazione orale di antibiotici
SE8603481L (sv) Topisk stralskyddsgel for mukosa
ES2131224T3 (es) Uso del formiato de calcio para la fabricacion de preparados de administracion oral.
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.
ATE259244T1 (de) Vermeidung von gastrointestinaler schädigung
PT912167E (pt) Granulos de derivados de hexa-hidropirazina administraveis por via oral
FI821324A0 (fi) Oxazolderivat
IT1274735B (it) Farmaco e vettore per le patologie infiammatorie ed erosive del tratto gastrointestinale a base di sucralfato allo stato di gel secco
RU94025798A (ru) Гидрофильный терпеноидный бальзам "таежный"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270503

Country of ref document: ES